Profile
Benjamin Scruggs currently works at Altis Biosystems, Inc., as Chief Executive Officer & Director, Veralox Therapeutics, Inc., as Director from 2021, IMMvention Therapeutix, Inc., as Director, Tune Therapeutics, Inc., as Senior Director from 2022, and Hatteras Venture Partners, as Partner from 2025.
Dr. Scruggs received his doctorate degree in 2012 from Washington University in St. Louis and undergraduate degree in 2006 from Vanderbilt University.
Benjamin Scruggs active positions
| Companies | Position | Start |
|---|---|---|
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Private Equity Investor | 2020-12-31 |
IMMvention Therapeutix, Inc.
IMMvention Therapeutix, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies | Director/Board Member | - |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company | Director/Board Member | 2021-05-31 |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. BiotechnologyHealth Technology Operates epigenome treatment medicines | Director/Board Member | 2021-12-31 |
Altis Biosystems, Inc.
Altis Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Develops stem cell technology designed to recreate the human intestinal epithelium and colonic epithelium for compound screening and microbiome research | Chief Executive Officer | 2023-01-31 |
Training of Benjamin Scruggs
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Finance |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company | Health Technology |
Altis Biosystems, Inc.
Altis Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Develops stem cell technology designed to recreate the human intestinal epithelium and colonic epithelium for compound screening and microbiome research | Health Technology |
IMMvention Therapeutix, Inc.
IMMvention Therapeutix, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies | Health Technology |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. BiotechnologyHealth Technology Operates epigenome treatment medicines | Health Technology |
- Stock Market
- Insiders
- Benjamin Scruggs
















